Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 5

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide

Authors Carl E Stafstrom

Published Date October 2009 Volume 2009:5 Pages 547—551

DOI http://dx.doi.org/10.2147/NDT.S5300

Published 23 October 2009

Carl E Stafstrom

Section of Pediatric Neurology, Departments of Neurology and Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Objective: This review summarizes the treatment of Lennox-Gastaut syndrome, an intractable epileptic encephalopathy of early childhood. In particular, the review focuses on rufinamide, a recently released anticonvulsant medication with reported effectiveness in this epilepsy syndrome.

Methods: A systematic literature search (PubMed) was performed to review the existing literature pertaining to the treatment of Lennox-Gastaut syndrome as well as studies involving rufinamide as an anticonvulsant medication.

Results: The published literature to date documents a beneficial effect of rufinamide on children over 4 years old with Lennox-Gastaut syndrome. Studies indicate a significant decrease in tonic and atonic seizure frequency as well as total seizure frequency compared to placebo-treated children. Rufinamide appears to be well tolerated and a safe medication, somnolence and vomiting being the most common side effects.

Conclusions: Rufinamide is a promising adjunctive therapy for Lennox-Gastaut syndrome, an intractable childhood epilepsy. To ensure its optimal effectiveness, clinicians must be familiar with the medication’s clinical response profile and potential for adverse effects.

Keywords: pediatric, epilepsy, epileptic encephalopathy, Lennox-Gastaut syndrome, rufinamide

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Ag-plasma modification enhances bone apposition around titanium dental implants: an animal study in Labrador dogs

Qiao SC, Cao HL, Zhao X, Lo HW, Zhuang LF, Gu YX, Shi JY, Liu XY, Lai HC

International Journal of Nanomedicine 2015, 10:653-664

Published Date: 14 January 2015

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

Cardama GA, Gonzalez N, Ciarlantini M, Gandolfi Donadío L, Comin MJ, Alonso DF, Menna PL, Gomez DE

OncoTargets and Therapy 2014, 7:2021-2033

Published Date: 30 October 2014

Evaluation of the relationship between corneal biomechanic and HbA1C levels in type 2 diabetes patients

Yazgan S, Celik U, Kaldirim H, Ayar O, Elbay A, Aykut V, Celik B, Taş M

Clinical Ophthalmology 2014, 8:1549-1553

Published Date: 19 August 2014

Cardiovascular program to improve physical fitness in those over 60 years old – pilot study

Castillo-Rodríguez A, Chinchilla-Minguet JL

Clinical Interventions in Aging 2014, 9:1269-1275

Published Date: 13 August 2014

Level of agreement between self-rated and clinician-rated instruments when measuring major depressive disorder in the Thai elderly: a 1-year assessment as part of the THAISAD study

Wongpakaran N, Wongpakaran T, Wannarit K, Saisavoey N, Pinyopornpanish M, Lueboonthavatchai P, Apisiridej N, Srichan T, Ruktrakul R, Satthapisit S, Nakawiro D, Hiranyatheb T, Temboonkiat A, Tubtimtong N, Rakkhajeekul S, Wongtanoi B, Tanchakvaranont S, Bookkamana P, Srisutasanavong U, Nivataphand R, Petchsuwan D

Clinical Interventions in Aging 2014, 9:377-382

Published Date: 25 February 2014

Synthesis of silver nanoparticles by using tea leaf extract from Camellia Sinensis

Loo YY, Chieng BW, Nishibuchi M, Radu S

International Journal of Nanomedicine 2012, 7:4263-4267

Published Date: 2 August 2012

Writing 3D patterns of microvessels

Juodkazis S

International Journal of Nanomedicine 2012, 7:3701-3702

Published Date: 13 July 2012